| Page 121 | Kisaco Research

Timeslot 1:  12.40pm - 1.00pm

Timeslot 2:  1.05pm - 1.25pm

Timeslot 3:  1.30pm - 1.50pm

Timeslot 4:  1.55pm - 2.15pm

Timeslot 5:  2.20pm - 2.40pm

Timeslot 6:  2.45pm - 3.05pm

Timeslot 7:  3.10pm - 3.30pm

Timeslot 8:  3.35pm - 3.55pm

Author:

Cal Lai

Chairman & CEO
Ask.vet



Cal Lai

Chairman & CEO
Ask.vet



Author:

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Author:

Paul Dick

President
Paul Dick & Associates

Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

Paul Dick

President
Paul Dick & Associates

Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

Author:

Karin Jager

Senior Vice President, Strategic Client Partnerships
Circa Healthcare

Karin Jager

Senior Vice President, Strategic Client Partnerships
Circa Healthcare
Regenerating the System from the Pioneering Farmers’ Perspective - RASEU 2024 Insights Report